Stay updated on BBI503 Combo with Anti-Cancer Agents Clinical Trial

Sign up to get notified when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBI503 Combo with Anti-Cancer Agents Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-19T20:00:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:25:10.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:12:26.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T16:50:30.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and major inclusion/exclusion criteria for a clinical trial involving BBI503 and various anti-cancer drugs. New drug names such as Nivolumab and Pembrolizumab have been added, indicating a shift in focus towards specific treatments.
    Difference
    35%
    Check dated 2025-04-16T12:36:45.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:42:43.000Z thumbnail image

Stay in the know with updates to BBI503 Combo with Anti-Cancer Agents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.